drugset / Trial / NCT01698164

Multi-centre Clinical Trial on Hormone Replacement Treatment in China

NCT01698164

Phase 4 Unknown 1200 enrolled Peking Union Medical College Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is to evaluate the benefit/risk of hormone replacement treatment among early menopausal women in China. This is a multi-centre, random, prospective study.

Timeline

Start
2008-12
Primary completion
2012-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 200 mg
Subject Ximingting Tablet Unknown
Comparator estradiol valerate Unknown 1 mg
Comparator medroxyprogesterone acetate Other / unclassified 4 mg